Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00365794Phase 2Completed
Phase 2, open-label, single-arm trial of Testosterone TEPI patch in Hypogonadism, sponsored by University of Southern California. Primary endpoints: Change in Total Mass and Regional Adipose Adiposity at 20 weeks, Change in Hepatic Lipid at 20 weeks and 1 more. Started Aug 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00365794.